159 related articles for article (PubMed ID: 19016284)
1. Reduction of Alzheimer's disease amyloid plaque load in transgenic mice by D3, A D-enantiomeric peptide identified by mirror image phage display.
van Groen T; Wiesehan K; Funke SA; Kadish I; Nagel-Steger L; Willbold D
ChemMedChem; 2008 Dec; 3(12):1848-52. PubMed ID: 19016284
[No Abstract] [Full Text] [Related]
2. Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display.
Wiesehan K; Buder K; Linke RP; Patt S; Stoldt M; Unger E; Schmitt B; Bucci E; Willbold D
Chembiochem; 2003 Aug; 4(8):748-53. PubMed ID: 12898626
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
[TBL] [Abstract][Full Text] [Related]
4. The bad seed in Alzheimer's disease.
Fryer JD; Holtzman DM
Neuron; 2005 Jul; 47(2):167-8. PubMed ID: 16039556
[TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
6. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
Solomon B
Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes.
Esposito M; Luccarini I; Cicatiello V; De Falco D; Fiorentini A; Barba P; Casamenti F; Prisco A
Mol Immunol; 2008 Feb; 45(4):1056-62. PubMed ID: 17850871
[TBL] [Abstract][Full Text] [Related]
8. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
9. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O
Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001
[TBL] [Abstract][Full Text] [Related]
10. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes.
Nilsson KP; Aslund A; Berg I; Nyström S; Konradsson P; Herland A; Inganäs O; Stabo-Eeg F; Lindgren M; Westermark GT; Lannfelt L; Nilsson LN; Hammarström P
ACS Chem Biol; 2007 Aug; 2(8):553-60. PubMed ID: 17672509
[TBL] [Abstract][Full Text] [Related]
11. Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation.
Schwarzman AL; Tsiper M; Gregori L; Goldgaber D; Frakowiak J; Mazur-Kolecka B; Taraskina A; Pchelina S; Vitek MP
Amyloid; 2005 Dec; 12(4):199-209. PubMed ID: 16399644
[TBL] [Abstract][Full Text] [Related]
12. Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease.
Larbanoix L; Burtea C; Laurent S; Van Leuven F; Toubeau G; Vander Elst L; Muller RN
Neurobiol Aging; 2010 Oct; 31(10):1679-89. PubMed ID: 19027991
[TBL] [Abstract][Full Text] [Related]
13. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques.
Li Q; Min J; Ahn YH; Namm J; Kim EM; Lui R; Kim HY; Ji Y; Wu H; Wisniewski T; Chang YT
Chembiochem; 2007 Sep; 8(14):1679-87. PubMed ID: 17705341
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden.
Kellner A; Matschke J; Bernreuther C; Moch H; Ferrer I; Glatzel M
Ann Neurol; 2009 Jan; 65(1):24-31. PubMed ID: 19194878
[TBL] [Abstract][Full Text] [Related]
15. Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
Chafekar SM; Malda H; Merkx M; Meijer EW; Viertl D; Lashuel HA; Baas F; Scheper W
Chembiochem; 2007 Oct; 8(15):1857-64. PubMed ID: 17763487
[TBL] [Abstract][Full Text] [Related]
16. Decorated plaques in Alzheimer's disease.
Tabira T
Ann Neurol; 2009 Jan; 65(1):4-6. PubMed ID: 19194874
[No Abstract] [Full Text] [Related]
17. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
[TBL] [Abstract][Full Text] [Related]
19. Active immunization against Alzheimer's beta-amyloid peptide using phage display technology.
Solomon B
Vaccine; 2007 Apr; 25(16):3053-6. PubMed ID: 17287054
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's cure?
Schub T
Lab Anim (NY); 2001 Apr; 30(4):12. PubMed ID: 11385737
[No Abstract] [Full Text] [Related]
[Next] [New Search]